JMIR Publications

ABSTRACT

Background:

The use of Artificial Intelligence (AI) methods in palliative care research is increasing. Most AI palliative care research involves the use of routinely collected data from electronic healthcare records patient data; however, there is little data about the of the views of palliative care healthcare professionals on the role of AI in practice. Determining the opinions of palliative care healthcare professionals on potential uses of AI in palliative care will be useful for policymakers and practitioners to determine, and inform, meaningful use of AI in palliative care practice.

Objective:

To explore palliative care healthcare professionals’ views on the use of AI for analysis of patient data in palliative care.

Methods:

Phenomenological study using qualitative semi-structured interviews of palliative care healthcare professionals with a minimum of one-year clinical experience in a hospice in the Northwest of England. Data were analysed using inductive thematic analysis.

Results:

We interviewed six palliative care professionals comprising of doctors, nurses and occupational therapies. AI was viewed positively, although most participants had not used this in practice. No participants had received training in AI and said that education in AI would be beneficial. Participants described potential benefits of palliative care AI, which included identification of people requiring palliative care interventions, and to evaluate patient experience. Participants highlighted security and ethical concerns of AI, related to data governance, efficacy, patient confidentiality and consent issues.

Conclusions:

This study highlights the importance of staff perceptions of AI in palliative care. Our findings support the role of AI in enhancing care, addressing education needs, and tackling trust, ethics, and governance issues. This study lays the groundwork for guidelines on AI implementation, urging further research on methodological, ethical, and practical aspects of AI in palliative care. Clinical Trial: NA